Nay C. T. H. Chit

The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survival

C. Robson, D. Dransfield, S. Nakjang, 2018, Oncotarget.

Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP12

C. Robson, K. Riabowol, J. Edwards, 2018, Oncogene.

Molecular mechanism of the TP 53-MDM 2-AR-AKT signalling network regulation by USP 12

C. Robson, J. Edwards, T. Karl, 2018 .